Elementis Valuation

Is EMNS.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of EMNS.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: EMNS.F ($1.91) is trading below our estimate of fair value ($4.84)

Significantly Below Fair Value: EMNS.F is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EMNS.F?

Key metric: As EMNS.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for EMNS.F. This is calculated by dividing EMNS.F's market cap by their current revenue.
What is EMNS.F's PS Ratio?
PS Ratio	1.3x
Sales	US$732.20m
Market Cap	US$988.01m

EMNS.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.7x
Enterprise Value/EBITDA	8x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does EMNS.F's PS Ratio compare to its peers?

The above table shows the PS ratio for EMNS.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.4x
ECVT Ecovyst	1.3x	5.2%	US$932.1m
VHI Valhi	0.4x	n/a	US$755.2m
SCL Stepan	0.8x	6.5%	US$1.7b
CCF Chase	3x	n/a	US$1.2b
EMNS.F Elementis	1.3x	3.4%	US$779.3m

Price-To-Sales vs Peers: EMNS.F is expensive based on its Price-To-Sales Ratio (1.3x) compared to the peer average (0.8x).

Price to Sales Ratio vs Industry

How does EMNS.F's PS Ratio compare vs other companies in the US Chemicals Industry?

11 Companies	Price / Sales	Estimated Growth	Market Cap
TSE Trinseo	0.04x	4.1%	US$157.18m
ALTO Alto Ingredients	0.1x	3.1%	US$108.07m
BON Bon Natural Life	0.3x	n/a	US$7.46m
ABLT American Biltrite	0.02x	n/a	US$2.91m

11 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: EMNS.F is good value based on its Price-To-Sales Ratio (1.3x) compared to the US Chemicals industry average (1.5x).

Price to Sales Ratio vs Fair Ratio

What is EMNS.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EMNS.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	1.3x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate EMNS.F's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Ecora Resources

UK£163.0m

Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.

ECRA.F

UK£0.81

-4.6%

-30.1%

CMOC Group

HK$159.6b

Engages in the mining, beneficiation, smelting, and refining of base and rare metals.

CMCL.F

HK$0.70

-9.4%

19.6%

Chemtrade Logistics Income Fund

CA$1.4b

Offers industrial chemicals and services in Canada, the United States, and South America.

CGIF.F

CA$8.16

-0.5%

25.0%